Active — Not RecruitingNot Applicable

A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women

United States50 participantsStarted 2024-06-07

Plain-language summary

This randomized, triple-blind, placebo-controlled trial will evaluate the efficacy of Live Conscious's Beyond Hormone supplement in regulating hormone production in women. The study involves 50 generally healthy female participants aged 25-45 who are not menopausal. The trial spans three menstrual cycles and assesses both objective hormone levels and subjective well-being through blood tests and questionnaires, respectively.

Who can participate

Age range25 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female at-birth, aged 25-45. * Not menopausal or perimenopausal. * Regularly menstruating. * Not taking any medication, supplement, or vitamin affecting hormone levels. * Generally healthy and not living with any uncontrolled chronic disease. Exclusion Criteria: * Medical conditions or treatments affecting hormonal regulation. * Endocrine disorders, gynecological or reproductive health conditions. * Use of hormonal contraceptives or hormone therapy. * Recent major illness or surgery. * Severe allergies or hypersensitivities.

What they're measuring

Hormone Levels Blood Panel (estradiol, testosterone, DHEA, insulin, and progesterone)

Timeframe: Baseline (Day 0), Midline (Day 45), and Endline (Day 90)

Trial details

NCT IDNCT06531668

SponsorScale Media Inc

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-09-07

View on ClinicalTrials.gov More Hormone Regulation trials